ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

March 7, 2003

DCCP Board Oks Fur New Concepts

July 17, 1981

Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals

April 18, 1986

Obituaries: Keith Amos, Trudy Small, and Kie Kian Ang

June 21, 2013

Also New AACR President Lynn Matrisian plans emphasis on enhancing communication.

April 2, 2004

NCI’s Hawk To Lead Prevention Division At M.D. Anderson.

November 16, 2007